Literature DB >> 12222664

Preliminary evaluation of anti-inflammatory and anti-arthritic activity of S. lappa, A. speciosa and A. aspera.

A B Gokhale1, A S Damre, K R Kulkami, M N Saraf.   

Abstract

Saussurea lappa, Argyreia speciosa and Achyranthes aspera are well known Indian medicinal plants used in the indigenous systems of medicine for the treatment of inflammatory conditions. The ethanolic extracts of the plants at the doses of 50, 100 and 200 mg/kg, p.o. were screened for their effect on acute and chronic inflammation induced in mice and rats. S. lappa and A. speciosa were found to significantly inhibit paw edema induced by carrageenan and Freund's complete adjuvant and to prevent accumulation of inflammatory cells in carrageenan-induced peritonitis at doses of 50-200 mg/kg. A. aspera inhibited these inflammatory responses at doses of 100-200 mg/kg. The studies reveal that the ethanolic extracts of S. lappa, A. speciosa and A. aspera possess anti-inflammatory and anti-arthritic activity and support the rationale behind the traditional use of these plants in inflammatory conditions.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12222664     DOI: 10.1078/09447110260571689

Source DB:  PubMed          Journal:  Phytomedicine        ISSN: 0944-7113            Impact factor:   5.340


  23 in total

1.  Hepatoprotective and antioxidant effects of Argyreia speciosa in rats.

Authors:  P V Habbu; R A Shastry; K M Mahadevan; Hanumanthachar Joshi; S K Das
Journal:  Afr J Tradit Complement Altern Med       Date:  2008-01-22

2.  Anticonvulsant Activity of Argyreia speciosa in Mice.

Authors:  N S Vyawahare; S L Bodhankar
Journal:  Indian J Pharm Sci       Date:  2009-03       Impact factor: 0.975

3.  Identification of novel anti-inflammatory agents from Ayurvedic medicine for prevention of chronic diseases: "reverse pharmacology" and "bedside to bench" approach.

Authors:  Bharat B Aggarwal; Sahdeo Prasad; Simone Reuter; Ramaswamy Kannappan; Vivek R Yadev; Byoungduck Park; Ji Hye Kim; Subash C Gupta; Kanokkarn Phromnoi; Chitra Sundaram; Seema Prasad; Madan M Chaturvedi; Bokyung Sung
Journal:  Curr Drug Targets       Date:  2011-10       Impact factor: 3.465

4.  Evaluation of Analgesic and Anti-Inflammatory Activity of Extract of Holoptelea Integrifolia and Argyreia Speciosa in Animal Models.

Authors:  Bhavesh K Lalan; R S Hiray; B B Ghongane
Journal:  J Clin Diagn Res       Date:  2015-07-01

5.  Curcumae Longae Rhizoma and Saussureae Radix Inhibit Nitric Oxide Production and Cannabinoid Receptor 2 Down-regulation.

Authors:  Takashi Tanikawa; Masashi Kitamura; Yasuhiro Hayashi; Takami Yokogawa; Yutaka Inoue
Journal:  In Vivo       Date:  2022 Jan-Feb       Impact factor: 2.155

6.  Analgesic and anti-inflammatory activity of Argyreia speciosa root.

Authors:  R S Bachhav; V S Gulecha; C D Upasani
Journal:  Indian J Pharmacol       Date:  2009-08       Impact factor: 1.200

7.  Biological Activities of Libidibia (Caesalpinia) ferrea var. parvifolia (Mart. ex Tul.) L. P. Queiroz Pod Preparations.

Authors:  A C C Freitas; N C A Ximenes; J S Aguiar; S C Nascimento; T U L Lins; L R Magalhães; L C B B Coelho; M G Carneiro-da-Cunha; T Gonçalves-Silva; M T S Correia
Journal:  Evid Based Complement Alternat Med       Date:  2012-05-23       Impact factor: 2.629

8.  Amelioration effects against N-nitrosodiethylamine and CCl(4)-induced hepatocarcinogenesis in Swiss albino rats by whole plant extract of Achyranthes aspera.

Authors:  R Kartik; Ch V Rao; S P Trivedi; P Pushpangadan; G D Reddy
Journal:  Indian J Pharmacol       Date:  2010-12       Impact factor: 1.200

9.  Argyreia speciosa (Linn. f.) sweet: A comprehensive review.

Authors:  V J Galani; B G Patel; N B Patel
Journal:  Pharmacogn Rev       Date:  2010-07

10.  Efficacy of modified LiuJunZi decoction on functional dyspepsia of spleen-deficiency and qi-stagnation syndrome: a randomized controlled trial.

Authors:  Shengsheng Zhang; Luqing Zhao; Hongbing Wang; Chuijie Wang; Suiping Huang; Hong Shen; Wei Wei; Lin Tao; Tao Zhou
Journal:  BMC Complement Altern Med       Date:  2013-03-02       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.